Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV, Single-arm, Open-label Study to Evaluate the Efficacy and Safety of 100 mg SC Depemokimab Monotherapy Without Concomitant Use of Intranasal Corticosteroids (INCS) in Japanese Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Are Inadequately Controlled With Standard Treatment

NCT07701967 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT07701967
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07701967 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV, Single-arm, Open-label Study to Evaluate the Efficacy and Safety of 100 mg SC Depemokimab Monotherapy Without Concomitant Use of Intranasal Corticosteroids (INCS) in Japanese Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Are Inadequately Controlled With Standard Treatment
Lead sponsor
GlaxoSmithKline
Phase
Phase 4
Overall status
Recruiting
Start date
July 15, 2026
Completion date
June 13, 2028
Enrollment
28 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

nasal polyps